Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

Journal of Clinical Investigation

Volumn 108, Issue 12, 2001, Pages 1853-1863

  Oldfield, Matthew D ^a   Bach, Leon A ^a   Forbes, Josephine M ^a   Nikolic Paterson, David ^b   McRobert, Anne ^a   Thallas, Vicki ^a   Atkins, Robert C ^b   Osicka, Tanya ^a   Jerums, George ^a   Cooper, Mark E ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA ACTIN; CYTOKINE; IODINE 125; NEUTRALIZING ANTIBODY; PHENYL GROUP; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; DIABETIC NEPHROPATHY; EPITHELIUM; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0035661067     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11951     Document Type: Article

References (53)

1. Nonenzymatic glycosylation and the pathogenesis of diabetic complications
2. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats
3. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat
4. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins
5. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): A new member of the AGE-receptor complex
6. Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors
7. Two novel rat liver membrane proteins that bind advanced glycosylation end products: Relationship to macrophage receptor for glucose-modified proteins
8. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products
9. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling
10. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
11. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
12. The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation
13. An advanced glycation end product cross-link breaker can reverse age-related increases in myocardial stiffness
14. Breakers of advanced glycation end products restore large artery properties in experimental diabetes
15. The renal tubulointerstitium in diabetes mellitus
16. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria
17. Myofibroblast-like cells produce mRNA for type I and III procollagens in chronic active hepatitis
18. Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy
19. Transdifferentiation comes of age
20. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro
21. High-affinity-receptormediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules
22. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
23. The quantification of protein amino groups by the trinitrobenzenesulfonic acid method: A reexamination
24. The preparation of 131I-labelled human growth hormone of high specific radioactivity
25. Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy
26. A rapid and sensitive method for quantification of microgram quantities of protein utilising the principle of protein dye binding
27. LIGAND: A computerized analysis of ligand binding data
28. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury
29. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues
30. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
31. Human tenal cottical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury
32. Guiding principles of specimen preservation for confocal fluorescence microscopy
33. Effects of genetic hypertension on diabetic nephropathy in the rat - Functional and structural characteristics
34. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment
35. Renoprotective effects of a novel inhibitor of advanced glycation
36. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycationmodified proteins to a conserved motif
37. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface
38. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells
39. Expression of receptors for advanced glycation end products in peripheral occlusive vascular disease
40. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
41. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factorbeta 1-dependent mechanism in vitro
42. Induction of TGF-beta 1 synthesis in D-glucose primed human proximal tubular cells by IL-1 beta and TNF alpha
43. Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells
44. Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding
45. Expression of receptors for advanced glycosylated end-products in renal disease
46. The endothelial cell binding site for advanced glycation end products consists of a complex: An integral membrane protein and a lactoferrin-like polypeptide
47. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease
48. Transforming growth factor beta contributes to progressive diabetic nephropathy
49. Expression of transforming growth factorbeta isoforms in human glomerular diseases
50. Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats
51. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor OPB-9195
52. Expression of cycoskeletal proteins during the course of experimental diabetic nephropathy
53. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats